NIA funding for Alzheimer’s and dementia research increases dramatically


NIA appropriations for Alzheimer’s disease and related dementias (ADRD) has increased to $400 million in FY 2017. And this, along with increases to NIA’s general appropriation, raised the general funding line “substantially,” according to Robin Barr, NIA’s Director of DEA. He adds: “We hope we have unleashed a wave of research on aging and on Alzheimer’s that will help generate the breakthroughs we so urgently need in our rapidly aging society.”

Related Resources

Robin Barr's post

NIA funding, FY 2017